Based on these observations, one can contemplate the use of ACEI/ARBs can increase ACE2 expression and intensify SARS-CoV-2 entry leading to severe COVID-19 (Figure 1(Fig. 1)). The gene discussed is ACE2; the disease is COVID-19.